FMP
NeuroPace, Inc.
NPCE
NASDAQ
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
13.98 USD
-0.02 (-0.143%)
About
ceo
Mr. Joel D. Becker
sector
Healthcare
industry
Medical - Devices
website
https://www.neuropace.com
exchange
NASDAQ
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
CIK
0001528287
ISIN
US6412881053
CUSIP
641288105
Address
455 North Bernardo Avenue
Phone
650 237 2700
Country
US
Employee
171
IPO Date
Apr 22, 2021
Key Executives
